Michael V. Lewis, Director, 10% Owner at HISTOGENICS CORP (HSGX), bought 1,153,420 shares at $11.00 ($4.4M) on 2014-12-08, disclosed to the SEC on 2014-12-08.
Open-market purchase of $4.4M HSGX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 747,000 | $0 | 0.0% |
| 2 | $0.76 | 11,502 | $9K | 0.2% |
| 3 | $11.00 | 394,918 | $4.3M | 99.8% |
| Total | $3.77 avg | 1,153,420 | $4.4M | 100% |
| Filing → |
| RLD | BUY | 2011-11-09 | $1000K | — | Filing → |
| RLD | SELL | 2010-12-10 | $30.1M | — | Filing → |
| RLD | SELL | 2010-07-19 | — | — | Filing → |